Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel antibacterial agents described in recent patent by British Biotech

Nov. 21, 2000

R&D at Lilly leads to discovery of new series of 5-HT reuptake inhibitors

Nov. 21, 2000

New anti-HIV agents synthesized in Korea show high therapeutic index

Nov. 21, 2000

PGE1 derivatives from Taisho and use in cardiovascular disorders

Nov. 21, 2000

Synthesis and use of new integrin antagonists in the therapy of asthma

Nov. 21, 2000

Antidiabetic imidazoles in the Sankyo pipeline

Nov. 21, 2000

Krenitsky presents pyrimidine-based neurotrophic compounds

Nov. 21, 2000

New erythromycin derivatives exert potent antimycobacterial activity

Nov. 20, 2000

Recently issued patent covers Meiji Seika's new lipid-lowering agents

Nov. 20, 2000

Potential new treatments for urinary incontinence described by Sanofi-Synthelabo

Nov. 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...